Novavax IncAdd to My Watchlist

NVAX:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 6.66
    Last
  • 0.25  -3.62%
    Today's Change
  • 6.91
    Previous Close
  • Today
     
    4.08
    15.01
    52 Week Low - High
8:10 pm ET 6/24/2016
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding271 million
Market Cap$2 billion
Return on Equity ttm-71.72%
Last DividendNVAX:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.780
EPS: Year Est. 12/16 ttm-0.961
 
EPS: Quarterly Actual 3/16 -0.29
EPS: Quarterly Est. 6/16 -0.25
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-62.16
Company Description
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Revenue$36 million
Net Income$-157 million
Total Assets$386 million
Employees443
Web Sitewww.novavax.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!